The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome

By Minozzi Massimo   Costantino Demetrio   Guaraldi Claudia   Unfer Vittorio  

Gynecological Endocrinology, Vol. 27, Iss. 11, 2011-11 ,pp. : 920-924

Informa Healthcare

Access to resources Recommend Favorite

The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies

By Halperin Ilana J.   Sujana Kumar Shoba   Stroup Donna F.   Laredo Sheila E.  

Human Reproduction, Vol. 26, Iss. 1, 2011-01 ,pp. : 191-201

Oxford University Press

Access to resources Recommend Favorite

Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment

By Kilic Sevtap   Yilmaz Nafiye   Zulfikaroglu Ebru   Erdogan Gokcen   Aydin Murat   Batioglu Sertac  

Gynecological Endocrinology, Vol. 27, Iss. 9, 2011-09 ,pp. : 622-629

Informa Healthcare

Access to resources Recommend Favorite

Low‐dose combination of flutamide, metformin and an oral contraceptive for non‐obese, young women with polycystic ovary syndrome

By Ibáñez Lourdes  

Human Reproduction, Vol. 18, Iss. 1, 2003-01 ,pp. : 57-60

Oxford University Press

Access to resources Recommend Favorite

Flutamide–metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity

By Ibáñez Lourdes  

Human Reproduction, Vol. 19, Iss. 8, 2004-08 ,pp. : 1725-1727

Oxford University Press

Access to resources Recommend Favorite